European Companies Search Engine

EU funding (€3,139,984): Real World Handling of Protein Drugs - Exploration, Evaluation and Education Hor1 Jul 2021 EU Research and Innovation programme "Horizon"

Overview

Text

Real World Handling of Protein Drugs - Exploration, Evaluation and Education

RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients by applying smart tag technologies. Different parameters will be logged and combined with protein characterisation at different stages, as well as with information from EFPIA partners on their drugs in use. Statistical evaluation of the data will be used to identify patterns in handling that are linked to protein destabilisation occurrence and type of protein degradation. Focus interviews with personnel in hospital pharmacies, clinics and with patients/care givers will be used to understand current handling practice and what the desired handling instructions and limitations are. These insights will be used to design in-use mimicking stability protocols for the protein drugs in the project. Ultra-scaled-down devices for stability assessment will be designed to be used in early phase for efficient development cost effective and safe future protein therapies. Protocols and devices will be validated towards the collected handling data base. Interventions in hospital pharmacies using e.g. compounding robots will be investigated. Techniques to assess e.g. aggregate formation in the final drug preparation situation will be evaluated together with SMEs producing analytical tools and hospital pharmacists. The collected data and interviews will form the base of development of teaching materials directed towards different target groups: hospital pharmacists, nurses and patients/care givers. App developers will be active in this part to design attractive and efficient apps for teaching and collecting therapy performance data.


Funded Companies:

Company name Funding amount
ABBVIE Inc. €0.00
Astrazeneca AB €0.00
Azienda Ospedaliera Universitaria Integrata Verona €15,285.00
Azienda Ulss N3 Serenissima €16,250.00
BOEHRINGER INGELHEIM INTERNATIONALGESELLSCHAFT mbH €0.00
Centre for Process Innovation Ltd. LBG €456,035
Elsa Science AB €98,702
F. HOFFMANN-LA ROCHE AG €0.00
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i Sunyer €40,000
Hospital Clinic de Barcelona €0.00
ICU MEDICAL B.V. €0.00
Istituto Oncologico Veneto €0.00
LONZA AG €0.00
Lunds Universitet €534,695
MERCK KGaA €0.00
Pfizer Ltd. €0.00
Plurima S.p.A. €11,205.50
Probation Labs Sweden AB €28,048
Region Uppsala €130,445
Reumatikerforbundet €6,919.00
Rise Research Institutes OF Sweden AB €672,658
SANOFI-AVENTIS DEUTSCHLAND GmbH €0.00
Societa Italiana Di Farmacia Clinica E Terapia €16,924.00
TEVA PHARMACEUTICAL INDUSTRIES Ltd. €0.00
Universita Degli Studi Di Padova €272,500
University College London €325,349
University of Dundee €514,969

Source: https://cordis.europa.eu/project/id/101007939

The filing refers to a past date, and does not necessarily reflect the current state.

Creative Commons License The visualizations for "ABBVIE Inc. - EU funding (€3,139,984): Real World Handling of Protein Drugs - Exploration, Evaluation and Education" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.